Actively Recruiting
Clinical and Molecular Study of Endometriosis and Adenomyosis
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-11-20
5300
Participants Needed
1
Research Sites
1804 weeks
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
U
URC-CIC Paris Descartes Necker Cochin
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to determine whether endometriosis and adenomyosis are progressive diseases, in terms of symptoms (pain, abnormal uterine bleeding and infertility), anatomical lesions size, and recurrences. We also aimed to address molecular questions on immune dialogues between ectopic lesions and the eutopic endometrium, auto-immunity in endometriosis and adenomyosis and the role of the microbiota in their respective pathophysiologies.
CONDITIONS
Official Title
Clinical and Molecular Study of Endometriosis and Adenomyosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged between 18 and 42 years old
- Receiving care for pelvic pain, infertility, or a pelvic mass
- Have a radiological diagnosis made by a referral practitioner or have had surgery in the department
You will not qualify if you...
- HIV-positive or infected with HBV or HCV
- Currently pregnant
- Have a cancer diagnosis
- Refuse to sign consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Port Royal, hospital cochin
Paris, France, 75014
Actively Recruiting
Research Team
C
Charles Chapron, MD
CONTACT
L
Laurence Lecomte, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here